earnings
confidence high
sentiment positive
materiality 0.80
Progyny reports record FY23 revenue $1.09B (+38%); guides FY24 $1.285-$1.315B
Progyny, Inc.
2023-FY EPS reported
$0.62
revenue$1,088,598,000
- FY23 revenue $1,088.6M (+38% YoY); net income $62.0M ($0.62 diluted EPS), adj. EBITDA $187.1M (+49%).
- Q4 revenue $269.9M (+26%); net income $13.5M ($0.13 EPS); adj. EBITDA $43.2M (+31%).
- Clients grew to 392 as of Dec 31, 2023, from 288 a year earlier; expects >460 clients in 2024.
- FY24 revenue guidance $1.285-$1.315B (+18-21%), adj. EBITDA $224-$232M, adj. EPS $1.54-$1.59.
- Q1 2024 revenue guided $285-$292M (+10-13%); cites ~$15M headwind from short-term treatment mix shift.